A Novel Strategy to Improve the Therapeutic Efficacy of Gemcitabine for Non-Small Cell Lung Cancer by the Tumor-Penetrating Peptide iRGD
Tóm tắt
Từ khóa
Tài liệu tham khảo
R Siegel, 2014, Cancer statistics, 2014, CA: a cancer journal for clinicians, 64, 9
H Ren, 2009, Antibodies targeting hepatoma-derived growth factor as a novel strategy in treating lung cancer, Molecular cancer therapeutics, 8, 1106, 10.1158/1535-7163.MCT-08-0779
IY Kim, 2009, Antitumor activity of EGFR targeted pH-sensitive immunoliposomes encapsulating gemcitabine in A549 xenograft nude mice. Journal of controlled release: official journal of the, Controlled Release Society, 140, 55, 10.1016/j.jconrel.2009.07.005
H Wang, 2006, Chemotherapy and chemosensitization of non-small cell lung cancer with a novel immunomodulatory oligonucleotide targeting Toll-like receptor 9, Molecular cancer therapeutics, 5, 1585, 10.1158/1535-7163.MCT-06-0094
D Ferrigno, 2000, Second-line chemotherapy for recurrent non-small cell lung cancer: do new agents make a difference?, Lung cancer, 29, 91, 10.1016/S0169-5002(00)00112-4
P Yang, 2005, Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003, Chest, 128, 452, 10.1378/chest.128.1.452
MM Mortenson, 2004, Effects of the proteasome inhibitor bortezomib alone and in combination with chemotherapy in the A549 non-small-cell lung cancer cell line, Cancer chemotherapy and pharmacology, 54, 343, 10.1007/s00280-004-0811-4
SG Spiro, 2002, Lung cancer—where are we today? Current advances in staging and nonsurgical treatment, American journal of respiratory and critical care medicine, 166, 1166, 10.1164/rccm.200202-070SO
H Cortes-Funes, 2002, New treatment approaches for lung cancer and impact on survival, Seminars in oncology, 29, 26, 10.1016/S0093-7754(02)70171-1
B Higgins, 2004, Antitumor activity of erlotinib (OSI-774, Tarceva) alone or in combination in human non-small cell lung cancer tumor xenograft models, Anti-cancer drugs, 15, 503, 10.1097/01.cad.0000127664.66472.60
K Cao, 2012, Noxa enhances the cytotoxic effect of gemcitabine in human ovarian cancer cells, Cancer biotherapy & radiopharmaceuticals, 27, 259, 10.1089/cbr.2011.1126
NM Cerqueira, 2007, Understanding ribonucleotide reductase inactivation by gemcitabine, Chemistry, 13, 8507, 10.1002/chem.200700260
MD Shelley, 2011, Gemcitabine chemotherapy for the treatment of metastatic bladder carcinoma, BJU international, 108, 168, 10.1111/j.1464-410X.2011.10341.x
MK Kim, 2011, The C-terminal region of Bfl-1 sensitizes non-small cell lung cancer to gemcitabine-induced apoptosis by suppressing NF-kappaB activity and down-regulating Bfl-1, Molecular cancer, 10, 98, 10.1186/1476-4598-10-98
G Marx, 2002, Non-platinum gemcitabine combinations in non-small cell lung cancer, Lung cancer, 38, S51, 10.1016/S0169-5002(02)00358-6
L Kraus-Berthier, 2000, Histology and sensitivity to anticancer drugs of two human non-small cell lung carcinomas implanted in the pleural cavity of nude mice. Clinical cancer research: an official journal of the, American Association for Cancer Research, 6, 297
J Dancey, 1997, Non-small cell lung cancer: an overview of current management, European journal of cancer, 33, S2, 10.1016/S0959-8049(96)00325-5
KN Sugahara, 2009, Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors, Cancer Cell, 16, 510, 10.1016/j.ccr.2009.10.013
CH Heldin, 2004, High interstitial fluid pressure—an obstacle in cancer therapy, Nat Rev Cancer, 4, 806, 10.1038/nrc1456
AJ Primeau, 2005, The distribution of the anticancer drug Doxorubicin in relation to blood vessels in solid tumors, Clinical cancer research: an official journal of the American Association for Cancer Research, 11, 8782, 10.1158/1078-0432.CCR-05-1664
JH Baker, 2008, Direct visualization of heterogeneous extravascular distribution of trastuzumab in human epidermal growth factor receptor type 2 overexpressing xenografts. Clinical cancer research: an official journal of the, American Association for Cancer Research, 14, 2171
KN Sugahara, 2009, Tissue-penetrating delivery of compounds and nanoparticles into tumors, Cancer cell, 16, 510, 10.1016/j.ccr.2009.10.013
S Su, 2013, iRGD-coupled responsive fluorescent nanogel for targeted drug delivery, 34, 3523
KN Sugahara, 2010, Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs, Science, 328, 1031, 10.1126/science.1183057
Q Zhang, 2012, Factor VII light chain-targeted lidamycin shows intensified therapeutic efficacy for liver cancer, Cancer biotherapy & radiopharmaceuticals, 27, 384, 10.1089/cbr.2012.1209
K Aizawa, 2013, Development of ferret as a human lung cancer model by injecting 4-(Nmethyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK), Lung cancer, 82, 390, 10.1016/j.lungcan.2013.09.012
C Pellet-Many, 2008, Neuropilins: structure, function and role in disease, The Biochemical journal, 411, 211, 10.1042/BJ20071639
L Roth, 2012, Transtumoral targeting enabled by a novel neuropilin-binding peptide, Oncogene, 31, 3754, 10.1038/onc.2011.537
LR Wang, 2005, Pharmacokinetics of gemcitabine in Chinese patients with non-small-cell lung cancer, Journal of Zhejiang University Science B, 6, 446, 10.1631/jzus.2005.B0446
B Pauwels, 2005, Combined modality therapy of gemcitabine and radiation, The oncologist, 10, 34, 10.1634/theoncologist.10-1-34
R Takebayashi, 2013, [18F]Fluorodeoxyglucose accumulation as a biological marker of hypoxic status but not glucose transport ability in gastric cancer, J Exp Clin Cancer Res, 32, 34, 10.1186/1756-9966-32-34
T Teesalu, 2009, C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration, Proc Natl Acad Sci U S A, 106, 16157, 10.1073/pnas.0908201106
W Dai, 2015, A comprehensive study of iRGD-modified liposomes with improved chemotherapeutic efficacy on B16 melanoma, Drug Deliv, 22, 10, 10.3109/10717544.2014.903580
K Wang, 2014, Tumor penetrability and anti-angiogenesis using iRGD-mediated delivery of doxorubicin-polymer conjugates, Biomaterials, 35, 8735, 10.1016/j.biomaterials.2014.06.042
Zhang X, Yu, Zhang W-Q, Luo L-M, Song, Li D, et al. The antitumor activity of a doxorubicin loaded, iRGD-modified sterically-stabilized liposome on B16-F10 melanoma cells: in vitro and in vivo evaluation. International Journal of Nanomedicine. 2013:2473. <comment>doi: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://dx.doi.org/10.2147/ijn.s46962" xlink:type="simple">10.2147/ijn.s46962</ext-link></comment>
J Shen, 2014, iRGD conjugated TPGS mediates codelivery of paclitaxel and survivin shRNA for the reversal of lung cancer resistance, Mol Pharm, 11, 2579, 10.1021/mp400576f
R Du, 2014, Antitumor effect of iRGD-modified liposomes containing conjugated linoleic acid-paclitaxel (CLA-PTX) on B16-F10 melanoma, Int J Nanomedicine, 9, 3091
Z Hai-Tao, 2011, A tumor-penetrating peptide modification enhances the antitumor activity of endostatin in vivo, Anticancer Drugs, 22, 409, 10.1097/CAD.0b013e328342050d
G Gu, 2013, The influence of the penetrating peptide iRGD on the effect of paclitaxel-loaded MT1-AF7p-conjugated nanoparticles on glioma cells, Biomaterials, 34, 5138, 10.1016/j.biomaterials.2013.03.036
W Song, 2012, Methoxypoly(ethylene glycol)-block-Poly(L-glutamic acid)-Loaded Cisplatin and a Combination With iRGD for the Treatment of Non-Small-Cell Lung Cancers, Macromol Biosci, 12, 1514, 10.1002/mabi.201200145
Y Akashi, 2014, Anticancer effects of gemcitabine are enhanced by co-administered iRGD peptide in murine pancreatic cancer models that overexpressed neuropilin-1, Br J Cancer, 110, 1481, 10.1038/bjc.2014.49
Y Zhang, 2013, Codelivery of VEGF siRNA and gemcitabine monophosphate in a single nanoparticle formulation for effective treatment of NSCLC, Mol Ther, 21, 1559, 10.1038/mt.2013.120
C Gridelli, 2003, Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial, J Natl Cancer Inst, 95, 362, 10.1093/jnci/95.5.362
C Gridelli, 2008, The MILES-2G phase 2 study of single-agent gemcitabine with prolonged constant infusion in advanced non-small cell lung cancer elderly patients, Lung Cancer, 61, 67, 10.1016/j.lungcan.2007.12.002
V Bianco, 2002, Gemcitabine as single agent chemotherapy in elderly patients with stages III-IV non-small cell lung cancer (NSCLC): a phase II study, Anticancer Res, 22, 3053
E Quoix, 2005, First line chemotherapy with gemcitabine in advanced non-small cell lung cancer elderly patients: a randomized phase II study of 3-week versus 4-week schedule, Lung Cancer, 47, 405, 10.1016/j.lungcan.2004.08.012
G Altavilla, 2000, Gemcitabine as single agent in the treatment of elderly patients with advanced non small cell lung cancer, Anticancer Res, 20, 3675
S Ricci, 2000, Gemcitabine monotherapy in elderly patients with advanced non-small cell lung cancer: a multicenter phase II study, Lung Cancer, 27, 75, 10.1016/S0169-5002(99)00098-7
AJ Sanchez, 2006, Crimean-congo hemorrhagic fever virus glycoprotein precursor is cleaved by Furin-like and SKI-1 proteases to generate a novel 38-kilodalton glycoprotein, Journal of virology, 80, 514, 10.1128/JVI.80.1.514-525.2006